FindTrial
Sign In

Study Of Post Tuberculosis Lung Disease In Adults With Drug Sensitive Pulmonary Tuberculosis.

Study Of Post Tuberculosis Lung Disease In Adults With Drug Sensitive Pulmonary Tuberculosis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077107
Enrollment
100
Registered
2024-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Rohit Raj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ADULTS BETWEEN 18-65 YEARS OF AGE WHO COMPLETED DAILY DRUG REGIMEN FOR DRUG SENSITIVE PULMONARY TUBERCULOSIS AS PER NTEP GUIDELINES.

Exclusion criteria

Exclusion criteria: PATIENTS with previously Diagnosed chronic lung pathology like COPD, Asthma,ILD,PAH and Extra pulmonary Tuberculosis.

Design outcomes

Primary

MeasureTime frame
Proportion Of patients of Drug Sensitive Pulmonary Tuberculosis who develop PTLD at the completion of Treatment.Timepoint: Proportion Of patients of Drug Sensitive Pulmonary Tuberculosis who develop PTLD at the completion of Treatment.—

Secondary

MeasureTime frame
Clinico-Radiological and Functional Outcomes of Drug Sensitive Pulmonary Tuberculosis in Adults as per NTEP guidelines at the completion of treatment.Timepoint: After completion of treatment as per NTEP guidelines.—

Countries

India

Contacts

Public ContactDr Naresh Kumar

Maulana Azad Medical College

drnareshmamc@gmail.com9953946064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026